“…Purely surgical ligation of patent ductus arteriosus was excluded from this study. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Prevalence survey data from recent studies in Zambia were used to capture the effects of spatial clustering of patent infections. RESULTS: RCD proved most effective at low prevalence. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Infected Groups (A, B, C, E, and F) showed a pre-patent period 2 days post infection (P.I) with mean parasitic counts of 3.93 ± 2.38, 2.46 ± 2.20, 0.67 ± 0.77, 4.60 ± 4.45, and 1.53 ± 1.44, respectively, which continued unabated in groups treated with the extract.The pack cell volume did not decline significantly in the in Groups A and B. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…MAIN OUTCOME MEASURES: In each practice the following were measured: the timing of the largest changes, steepness of the change slope (change in proportion per month), and magnitude of the change for two example time series (expiry of the Cerazette patent in 2012, leading to cheaper generic desogestrel alternatives becoming available; and a change in antibiotic prescribing guidelines after 2014, favouring nitrofurantoin over trimethoprim for uncomplicated urinary tract infection (UTI)). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…EXPOSURES: NEC prevention practices (probiotics, feeding, donor milk) using responses of an on-line pre-piloted questionnaire containing 10 questions and factors associated with NEC in literature (antenatal steroids, c-section, indomethacin treated patent ductus arteriosus and sepsis) using cohort data. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Informed by scientific evidence and the voices of patients, families and healthcare professionals, the Person-Centered Care Certification Programme was developed as a comprehensive measure of PCC (Person-Centered Care Certification is a registered trademark of Planetree Registered in the US Patent and Trademark Office). Ten years after its development, the programme was redesigned to offer a more complete evaluative framework to focus organisations’ PCC efforts and better understand their impact. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…INTRODUCTION: The optimal management of patent ductus arteriosus (PDA) remains contentious. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…As a kind of Chinese patent medicine, Shujinjianyao pill (SJJYP) has a great curative effect on low back pain. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Initial echocardiogram revealed a large patent ductus arteriosus (PDA), and high pulmonary pressures with enlarged right ventricle. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Shenxian-Shengmai (SXSM) Oral Liquid is a CFDA-approved patent Chinese Herbal medicine, which has been clinically used for the treatment of bradycardia. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This study aimed to compare the concentrations of digoxin predicted by traditional regression modeling and artificial neural network (ANN) modeling for newborn infants given digoxin for clinically significant patent ductus arteriosus (PDA). METHODS: A retrospective chart review was conducted to obtain data on digoxin use for clinically significant PDA in a neonatal intensive care unit. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS AND RESULTS: This was a retrospective multicenter study of infants with ductal‐dependent pulmonary blood flow palliated with patent ductus arteriosus (PDA) stent or Blalock‐Taussig shunt (BTS) from 2008 to 2015. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHOD AND ANALYSIS: This multicentre, randomised controlled trial will recruit 200 patients who have fusiform AAA ≥50 mm/rapidly enlarging fusiform AAA, with patent IMA, and randomly allocate them either to a pre-emptive IMA embolisation group or non-embolisation control group in a ratio of 1:1. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…MRI, BAEP, echocardiogram and bronchoscopy revealed that he had persistent falcine sinus with a thin corpus callosum, left auditory pathway disorder, patent foramen ovale (2 mm), and tracheobronchomalacia with the right superior bronchus arising from the lateral posterior wall of the right main bronchus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: A systematic institution based cross-sectional study design was conducted from 1st March to 8th April 2016 among adult diabetes patent. Depression status was assessed by the Patient Health Questionnaire-9 (PHQ-9). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Shu-gan-qing-re (SGQR) formula, a Chinese patent medicine, has been well received by patients with GAD in Chinese clinical practice for years. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All laparoscopic revascularization procedures remained patent after discharge during a median follow-up time of 26 months (range 18–49 months). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVE: To evaluate the protective effects of Reduning Injection (热毒宁注射液, RDN), a patent Chinese medicine, on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in rats and its underlying mechanisms of action. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…While still there are only two vector-based vaccines on the human vaccine market, there is ample activity in the fields of patenting, preclinical research, and different stages of clinical research. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Our data demonstrated that the co-culture system with T-cells from uninfected dogs at 1:5 and 1:2 ratio did not control the infection, yielding to patent in vitro parasitism (≥80%), low NO production (≤5 μM) and IL-10 modulated (IFN-γ/IL-10≤2) immunological profile in vitro. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso